Delta‐6‐desaturase activity and arachidonic acid synthesis are increased in human breast cancer tissue
Authors:
Open Access
- 18 February 2013
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 104 (6) , 760-764
Abstract
Omega‐6 (n‐6) arachidonic acid (AA) and its pro‐inflammatory metabolites, including prostaglandin E2 (PGE2), are known to promote tumorigenesis. Delta‐6 desaturase (D6D) is the rate‐limiting enzyme for converting n‐6 linoleic acid (LA) to AA. Our objective was to determine if AA synthesis, specifically D6D activity, and PGE2 levels are increased in cancerous breast tissue, and whether these variables differ between estrogen receptor positive (ER+) and negative (ER−) breast cancers. Gas chromatography was performed on surgical breast tissue samples collected from 69 women with breast cancer. Fifty‐four had ER+ breast cancer, and 15 had ER− breast cancer. Liquid chromatography‐mass spectrometry was used to determine PGE2 levels. Lipid analysis revealed higher levels of LA metabolites (C18:3 n‐6, C20:3 n‐6, and AA) in cancerous tissue than in adjacent noncancerous tissue (P < 0.01). The ratio of LA metabolites to LA, a measure of D6D activity, was increased in cancerous tissue, suggesting greater conversion of LA to AA (P < 0.001), and was higher in ER− than in ER+ patients, indicating genotype‐related trends. Similarly, PGE2 levels were increased in cancerous tissue, particularly in ER− patients. The results showed that the endogenous AA synthetic pathway, D6D activity, and PGE2 levels are increased in breast tumors, particularly those of the ER− genotype. These findings suggest that the AA synthetic pathway and the D6D enzyme in particular may be involved in the pathogenesis of breast cancer. The development of drugs and nutritional interventions to alter this pathway may provide new strategies for breast cancer prevention and treatment.Keywords
This publication has 38 references indexed in Scilit:
- Inhibiting Delta-6 Desaturase Activity Suppresses Tumor Growth in MicePLOS ONE, 2012
- Antiestrogens and Their Therapeutic Applications in Breast Cancer and Other DiseasesAnnual Review of Medicine, 2011
- Triple negative breast cancer: unmet medical needsBreast Cancer Research and Treatment, 2010
- Triple-Negative Breast CancerDrugs, 2010
- Management of triple negative breast cancerThe Breast, 2010
- The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuumAnnals of Oncology, 2010
- Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progressionGenes, Chromosomes and Cancer, 2008
- Effects of dietary purified eicosapentaenoic acid (20:5(n − 3)) and docosahexaenoic acid (22:6(n − 3)) on fatty acid desaturation and oxidation in isolated rat liver cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Modification of liver fatty acid metabolism in mice by n − 3 and n − 6 Δ6-desaturase substrates and productsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Effect of dietary n − 3 and n − 6 fatty acids on fatty acid desaturation in rat liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991